1,133
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Multisystem thromboembolism in a COVID-19 patient: a case report

, , , , , , & show all
Pages 489-495 | Received 12 Feb 2021, Accepted 19 May 2021, Published online: 21 Jun 2021

References

  • Klok FA, Kruip MJHA, Van Der Meer NJM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–150.
  • Madjid M, Safavi-Naeini P, Solomon SD, et al. Potential effects of coronaviruses on the cardi ovascular system: a review. JAMA Cardiol. 2020;5:831.
  • Driggin E, Madhavan MV, Bikdeli B. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol. 2020. DOI:10.1016/j.jacc.2020.03.031
  • Campbell CM, Kahwash R. Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? Circulation. 2020;141:1739–1741.
  • Tan YK, Goh C, Leow AST, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature [published online ahead of print, 2020 Jul 13]. J Thromb Thrombolysis. 2020;1–9. DOI:10.1007/s11239-020-02228-y.
  • Taisheng L, Hongzhou L, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020;9(1):687–690.
  • Miesbach W, Makris M. COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clin Appl Thromb Hemost. 2020;26:1076029620938149.
  • Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. 2020;382:e38.
  • Violi F, Pastori D, Cangemi R, et al. Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge. Thromb Haemost. 2020;120(6):949–956.
  • Terrigno VR, Tan JL, Singh D, et al. Right atrial thrombus in a patient with COVID-19. Cureus. 2020 Jul 28;12(7):e9441. . PMCID: PMC7451074.
  • Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421–1424.
  • Trejo-Gabriel-Galán JM. Stroke as a complication and prognostic factor of COVID-19. Ictus como complicación y como factor pronóstico de COVID-19. Neurología. 2020;35(5):318–322.
  • Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with enoxaparin study group. N Engl J Med. 1999;341(11):793–800.
  • Poterucha TJ, Libby P, Goldhaber SZ. More than an anticoagulant: do heparins have direct anti-inflammatory effects? Thromb Haemost. 2017;117(3):437–444.
  • Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992 May 7;326(19):1240–1245.
  • European Working Group on Echocardiography. The European cooperative study on the clinical significance of right heart thrombi. Eur Heart J. 1989 Dec;10(12):1046–1059.
  • Wible BC, Buckley JR, Cho KH, et al. Safety and Efficacy of Acute Pulmonary Embolism Treated via Large-Bore Aspiration Mechanical Thrombectomy Using the Inari FlowTriever Device. J Vasc Interv Radiol. 2019 Sep;30(9):1370–1375. doi:10.1016/j.jvir.2019.05.024. Epub 2019 Jul 30. PMID: 31375449.